
To investigate factors associated with delays in receiving glucose lowering therapy in patients newly diagnosed with type 2 diabetes mellitus , and explore the preferential order and time of intensifications. Retrospective cohort study including 120 409 adults with T2DM initiating first to fourth line glucose lowering therapy in primary care between 2000 and 2018, using the UK Clinical Practice Research Datalink linked to Hospital Episode Statistics, Office of National Statistics death registration, and 2007 Index of Multiple Deprivation data. Results The longest delays to prescription of first line therapy were observed in older patients, of black or other ethnicities, and with multimorbidity. The majority were treated with metformin as the first line prescription, sulphonylurea as second line, dipeptidyl peptidase 4 inhibitor as third line, and insulin as fourth line...
Like
Save
Share